(Q43258119)

17 November 2017

title

Exposure-response analysis in patients with schizophrenia to assess the effect of asenapine on QTc prolongation (English)

1 reference

17 November 2017

0 references

1 reference

Sunny Chapel

1

1 reference

17 November 2017

Matt M Hutmacher

2

1 reference

17 November 2017

George Haig

3

1 reference

17 November 2017

Howard Bockbrader

4

1 reference

17 November 2017

Rik de Greef

5

1 reference

17 November 2017

Sheldon H Preskorn

6

1 reference

17 November 2017

Richard L Lalonde

7

1 reference

17 November 2017

language of work or name

1 reference

1 November 2009

1 reference

The Journal of Clinical Pharmacology

17 November 2017

published in

1 reference

17 November 2017

volume

49

1 reference

17 November 2017

issue

11

1 reference

17 November 2017

page(s)

1297-1308

1 reference

Prolongation of QTc interval and antipsychotics

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Drugs, QT interval prolongation and ICH E14: the need to get it right

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Performance characteristics for some typical QT study designs under the ICH E-14 guidance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

QTc interval prolongation and antipsychotic drug treatments: focus on sertindole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Ziprasidone in the management of schizophrenia : the QT interval issue in context

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Current schizophrenia drugs: efficacy and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

Torsades de Pointes associated with intravenous haloperidol in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009344855

21 January 2018

Identifiers

DOI

10.1177/0091270009344855

1 reference

17 November 2017

1 reference